Associated Papers
Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer.
Park C et al.
Cancer Immunology, Immunotherapy : Cii, 2024
39105849 (PubMed )
Supplement: 262_2024_3782_MOESM1_ESM.pdf
Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an N-of-1 clinical trial.
Shaheen MF et al.
Elife, 2022
AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation.
Boscolo E et al.
Angiogenesis, 2015
Select a paper to view details